Overview

Iron Supplement in the Prevention of Anemia in Female Breast Cancer Patients

Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy of intravenous iron supplementation in the prevention of anemia in patients receiving (neo)adjuvant breast cancer regimens.
Phase:
Phase 2
Details
Lead Sponsor:
Instituto do Cancer do Estado de São Paulo
Collaborator:
Fundação Faculdade de Medicina
Treatments:
Iron
Teferrol